DOW JONES21,105.60-811.56 -3.70%
S&P 5002,482.18-102.41 -3.96%
NASDAQ7,434.92-265.18 -3.44%

H.C. Wainwright Reiterates Buy on TRACON Pharmaceuticals, Lowers Price Target to $13

H.C. Wainwright analyst Edward White reiterates TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and lowers the price target from $18 to $13.

Benzinga · 02/28/2020 17:31

H.C. Wainwright analyst Edward White reiterates TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and lowers the price target from $18 to $13.